Covid-19 roundup: Stéphane Bancel sees December EUA for Moderna at earliest; Trump trashes Fauci as 'disaster' and 'idiot'
Stéphane Bancel’s new estimated timeline for Moderna’s Covid-19 vaccine puts his company on track to score an emergency use authorization in December — given the interim Phase results turn out positive in November.
Per the trial protocol, the first interim analysis of the Moderna vaccine’s efficacy will happen when 53 people in the entire study, which is enrolling 30,000 volunteers, get symptomatic disease. The data safety monitoring board would then review the unblinded results and check the breakdown between the vaccinated and those given placebo.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 94,100+ biopharma pros reading Endpoints daily — and it's free.